Scynexis (SCYX) Change in Account Payables (2023 - 2026)
Scynexis (SCYX) posted Change in Account Payables of $906000.0 for Q1 2026, up 172.95% on a QoQ basis from -$1.2 million in Q4 2025, and up 555.28% year-over-year from $138262.3 in Q1 2025.
Scynexis (SCYX) Change in Account Payables (2023 - 2026) Analysis & Trends
Scynexis' Change in Account Payables history runs 4 years deep, the most recent figure standing at $906000.0 for Q1 2026.
- Quarterly Change in Account Payables rose 555.28% year-over-year to $906000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.1 million (up 75.76% YoY) and the FY2025 annual result came in at -$2.2 million, up 15.7% from the prior year.
- Change in Account Payables was $906000.0 for Q1 2026 at Scynexis, up from -$1.2 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $3.6 million in Q4 2023 and bottomed at -$3.6 million in Q2 2024.
- A 4-year average of -$215846.2 and a median of -$199000.0 in 2025 frame the typical range for Change in Account Payables.
- Peak annual rise in Change in Account Payables reached 15175.0% in 2024, while the deepest fall reached 650.0% in 2024.
- Scynexis' Change in Account Payables stood at $3.6 million in 2023, then sank by 113.37% to -$484000.0 in 2024, then slumped by 156.61% to -$1.2 million in 2025, then jumped by 172.95% to $906000.0 in 2026.
- Business Quant data shows SCYX's Change in Account Payables at $906000.0 in Q1 2026, -$1.2 million in Q4 2025, and -$2.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 30.60 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Scynexis | 21.55 Mn | -15.20 Mn | - | 906,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 906,000.00 |
| Mar 31, 2026 | 906,000.00 |
| Dec 31, 2025 | -1.24 Mn |
| Dec 31, 2025 | -1.24 Mn |
| Sep 30, 2025 | -2.71 Mn |
| Sep 30, 2025 | -2.71 Mn |
| Jun 30, 2025 | 1.91 Mn |
| Jun 30, 2025 | 1.91 Mn |
| Mar 31, 2025 | -199,000.00 |
| Mar 31, 2025 | -199,000.00 |
| Dec 31, 2024 | -484,000.00 |
| Dec 31, 2024 | -484,000.00 |
| Sep 30, 2024 | -407,000.00 |
| Sep 30, 2024 | -407,000.00 |
| Jun 30, 2024 | -3.57 Mn |
| Jun 30, 2024 | -3.57 Mn |
| Mar 31, 2024 | 1.81 Mn |
| Mar 31, 2024 | 1.81 Mn |
| Dec 31, 2023 | 3.62 Mn |
| Dec 31, 2023 | 3.62 Mn |